The Group’s Supporters and donors help to support the valuable work of the Group without which it could not exist. Each one is engaged in controlling malaria and or NTDs through its R&D, control programmes in individual countries, or educating civil society of the dangers of malaria and other neglected tropical diseases.
Medicines for Malaria Venture
MMV is a not-for-profit public-private partnership whose mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs. MMV’s vision is a world in which these innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and help to ultimately eradicate this terrible disease.
Malaria No More UK are an innovative charity working tirelessly to end suffering and deaths from malaria. We back the global goal of near zero deaths by 2015. We save lives through high-impact awareness and fundraising campaigns and by making strategic investments in Africa where over 90% of all malaria deaths occur.
The UK Coalition against Neglected Tropical Diseases (NTDs) is a collaborative partnership between UK organisations actively engaged in NTD research, implementation and in advocating for effective sustainable NTD control programmes at scale.
The UK Coalition against NTDs works to raise awareness among UK, European, international policy makers and the broader health community of NTDs as a key barrier to attainment of the SDGs and poverty alleviation. Through targeting policy engagement, the coalition works to support effective approaches for the long term sustainable control of NTDs using evidence from existing research and programmes, and to ensure that NTD control is included within national, regional and international health and development frameworks.
Malaria Consortium is one of the world’s leading non-profit organisations specialising in the comprehensive control of malaria and other communicable diseases – particularly those affecting children under five.
Malaria Consortium works in Africa and Southeast Asia with communities, government and non-government agencies, academic institutions, and local and international organisations, to ensure good evidence supports delivery of effective services. A primary focus for the organisation is to strengthen the interface between research and implementation, practice and policy and health systems and disease control.
The PATH Malaria Vaccine Initiative (MVI) is a program of the international non-profit organization PATH. MVI was established in 1999 through an initial grant from the Bill & Melinda Gates Foundation.
Mission: To accelerate the development of malaria vaccines and catalyze timely access in endemic countries.
Vision: A world free from malaria.
MVI is pursuing a range of vaccine development approaches with an expanding circle of industry, academic, and government partners. MVI maintain a diverse portfolio of projects, including preclinical feasibility studies, translational projects, and one advanced clinical project.